OBJECTIVE: Higher dairy consumption has been suggested to reduce the risk of obesity and metabolic disturbances. The aim of our study was to investigate the prospective association between dairy consumption and changes in weight and metabolic disturbances. METHODS AND PROCEDURES: Baseline dairy intake (servings/day) was assessed by a semi-quantitative food-frequency questionnaire in 1,124 participants of the Hoorn Study. Linear and logistic regression analyses were performed to investigate the association between dairy intake and 6.4-year change in weight, fat distribution, and metabolic risk factors (glucoses, lipids, blood pressure) and the incidence of metabolic syndrome (MS). RESULTS: Baseline dairy consumption was not associated with changes in fasting and post-load glucose concentrations, serum lipid levels (high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, and triglycerides), or blood pressure, nor with the risk of developing the MS in 6.4 years (odds ratio with 95% confidence interval was 0.86 (0.52-1.42) comparing highest with lowest quartile of dairy consumption). In subjects with BMI < 25 kg/m(2), higher dairy consumption was significantly associated with an increase in BMI, weight, waist, and a decrease in high-density lipoprotein. DISCUSSION: Our results do not support the hypothesis that a higher dairy consumption protects against weight gain and development of metabolic disturbances in a Dutch elderly population.
OBJECTIVE: Higher dairy consumption has been suggested to reduce the risk of obesity and metabolic disturbances. The aim of our study was to investigate the prospective association between dairy consumption and changes in weight and metabolic disturbances. METHODS AND PROCEDURES: Baseline dairy intake (servings/day) was assessed by a semi-quantitative food-frequency questionnaire in 1,124 participants of the Hoorn Study. Linear and logistic regression analyses were performed to investigate the association between dairy intake and 6.4-year change in weight, fat distribution, and metabolic risk factors (glucoses, lipids, blood pressure) and the incidence of metabolic syndrome (MS). RESULTS: Baseline dairy consumption was not associated with changes in fasting and post-load glucose concentrations, serum lipid levels (high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, and triglycerides), or blood pressure, nor with the risk of developing the MS in 6.4 years (odds ratio with 95% confidence interval was 0.86 (0.52-1.42) comparing highest with lowest quartile of dairy consumption). In subjects with BMI < 25 kg/m(2), higher dairy consumption was significantly associated with an increase in BMI, weight, waist, and a decrease in high-density lipoprotein. DISCUSSION: Our results do not support the hypothesis that a higher dairy consumption protects against weight gain and development of metabolic disturbances in a Dutch elderly population.
Authors: Nikki C Bush; Jessica A Alvarez; Suzanne S Choquette; Gary R Hunter; Robert A Oster; Betty E Darnell; Barbara A Gower Journal: Obesity (Silver Spring) Date: 2010-03-04 Impact factor: 5.002
Authors: Mary M McGrane; Eve Essery; Julie Obbagy; Joan Lyon; Patricia Macneil; Joanne Spahn; Linda Van Horn Journal: Curr Cardiovasc Risk Rep Date: 2011-08-01
Authors: Dolores Corella; Maria Arregui; Oscar Coltell; Olga Portolés; Patricia Guillem-Sáiz; Paula Carrasco; Jose V Sorlí; Carolina Ortega-Azorín; Jose I González; Jose M Ordovás Journal: Obesity (Silver Spring) Date: 2010-12-30 Impact factor: 5.002
Authors: May A Beydoun; Marie T Fanelli-Kuczmarski; Hind A Beydoun; Greg A Dore; Jose A Canas; Michele K Evans; Alan B Zonderman Journal: Br J Nutr Date: 2018-03 Impact factor: 3.718
Authors: J Bruce German; Robert A Gibson; Ronald M Krauss; Paul Nestel; Benoît Lamarche; Wija A van Staveren; Jan M Steijns; Lisette C P G M de Groot; Adam L Lock; Frédéric Destaillats Journal: Eur J Nutr Date: 2009-03-04 Impact factor: 5.614